(R)-2,3-Dihydro-1H-Inden-1-Amine Hydrochloride

We are (R)-2,3-Dihydro-1H-Inden-1-Amine Hydrochloride CAS:10305-73-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:(R)-2,3-Dihydro-1H-Inden-1-Amine Hydrochloride
CAS.NO:10305-73-4
Synonyms:(R)-2,3-Dihydro-1H-Inden-1-Amine Hydrochloride
(R)-(-)-1-Aminoindanehydrochloride
(1R)-2,3-dihydro-1H-inden-1-amine,hydrochloride
(R)-2,3-Dihydro-1H-inden-1-amine hydrochloride
 
Physical and Chemical Properties:
Melting Point 232-234ºC
Molecular Formula C9H12ClN
Molecular Weight 169.651
 
Specification:
Appearance:Off-white to white powder
Assay(HPLC):≥99.0%
Melting Point:238-242ºC
Moisture:≤0.5%
Single impurity:≤0.3%
Total imputities:≤1.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Rasagiline Mesylate(CAS:161735-79-1).

(R)-2,3-Dihydro-1H-Inden-1-Amine Hydrochloride


Related News: The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.3,4,5-Trimethoxybenzaldehyde CAS:86-81-7 In recent years, with the increasing number of patent medicines whose patents have expired, the variety and quantity of generic drugs have also increased rapidly, which has brought huge market opportunities to the API market and the output of APIs has continued to increase.(S) -1-fenil-1,2,3,4-tetrahidroisoquinolina CAS:118864-75-8 ViiV, in which Pfizer and Shionogi have small stakes, said it received a so-called complete response letter (CRL) from the FDA in which the regulator questioned the treatment’s chemistry, manufacturing and controls process, but not its safety.2-Phenylacetamide CAS:103-81-1 Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.Active pharmaceutical ingredients affect the structure and function of the human body. Inactive ingredients in a pharmaceutical may be referred to as “bulk pharmaceutical chemicals (BPCs).”

Related Products
Product Name
3-(4-Methylbenzylidene)camphor View Details
Z-GLY-PRO-PHE-PRO-LEU-OH View Details
1,3-phenylenediamine View Details
2′-Deoxy-2′-fluorouridine manufacturer N-(2-amino-4,5,6,7-tetrahydrobenzo[d]thiazol-6-yl)acetamide hydrobromide manufacturer 2-Amino-6-bromobenzoic acid manufacturer 2-Fluoro-5-nitropyridine manufacturer 2-Bromo-2-methylpropionic acid manufacturer